Advanced search
Start date
(Reference retrieved automatically from Web of Science through information on FAPESP grant and its corresponding number as mentioned in the publication by the authors.)

Comprehensive evaluation of risk factors for neonatal hearing loss in a large Brazilian cohort

Full text
Show less -
Anastasio, Adriana R. T. [1] ; Yamamoto, Aparecida Y. [2] ; Massuda, Eduardo T. [3] ; Manfredi, Alessandra K. S. [1] ; Cavalcante, Juliana M. S. [1] ; Lopes, Bruno C. P. [3] ; Aragon, Davi C. [2] ; Boppana, Suresh [4] ; Fowler, Karen B. [4] ; Britt, William J. [4] ; Mussi-Pinhata, Marisa M. [2]
Total Authors: 11
[1] Univ Sao Paulo, Ribeirao Preto Med Sch, Dept Hlth Sci, Sao Paulo, SP - Brazil
[2] Univ Sao Paulo, Ribeirao Preto Med Sch, Dept Pediat, Sao Paulo, SP - Brazil
[3] Univ Sao Paulo, Dept Ophthalmol Otorhinolaryngol & Head & Neck Su, Ribeirao Preto Med Sch, Sao Paulo, SP - Brazil
[4] Univ Alabama Birmingham, Dept Pediat, Birmingham, AL 35294 - USA
Total Affiliations: 4
Document type: Journal article
Source: Journal of Perinatology; v. 41, n. 2 SEP 2020.
Web of Science Citations: 0

Objectives To determine the incidence and risk factors of hearing loss (HL) in Brazilian neonates. Study design 11,900 neonates were screened for hearing and congenital CMV (cCMV). Low and high-risk babies who did not pass their hearing screening and infants with cCMV were scheduled for a diagnostic audiologic evaluation. Results The incidence of HL was 2 per 1000 live-born infants (95% CI: 1-3). HL was higher in high-risk neonates than in low risk babies (18.6 vs. 0.3/1000 live births, respectively). Among infants exposed to isolated risk factors, association of HL with craniofacial abnormalities/syndromes (RR = 24.47; 95% CI: 5.9-100.9) and cCMV (RR = 9.54; 95% CI: 3.3-27.7) were observed. HL was 20 to 100-fold more likely in neonates exposed to ototoxic drugs in combination with cCMV or craniofacial/congenital anomalies. Conclusions Strategies for the prevention of cCMV and exposure to ototoxic drugs may decrease the incidence of HL in this population. (AU)

FAPESP's process: 13/06579-0 - Brazilian congenital cytomegalovirus, hearing and maternal secondary infection study (BraCHS Study)
Grantee:Marisa Marcia Mussi
Support type: Research Projects - Thematic Grants